INTRALIPID 20%
Google image searchProduct monograph
Active ingredient
soybean oil, 20 %/W/V
DIN: 02065673
Dosage form(s): EMULSION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: FRESENIUS KABI CANADA LTD
Date: 19-OCT-2015
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BA — Solutions for parenteral nutrition (ATC, ATC/DDD)
- B05BA02 — FAT EMULSIONS (ATC/DDD)
Pharmaceutical standard: MFR
